Wockhardt announced the filing of its fast-acting insulin analog, Aspart injection (ASPARAPID™), with the Drugs Controller General of India (DCGI). This significant milestone reflects Wockhardt's ...

Drug firm Wockhardt on Wednesday said it has approached the DCGI for marketing approval of a diabetes treatment medication. The company has filed its fast-acting insulin analog, Aspart injection, with ...

Wockhardt Limited is a global pharmaceutical and biotechnology organization providing affordable high-quality medicines for a healthier world. The Company is India's leading research-based global ...

Wockhardt has filed for marketing approval of its fast-acting insulin analog, Aspart injection, with the DCGI in India. This move aims to address the growing diabetes epidemic and provide patients ...

Drugmaker Wockhardt has approached the Drug Controller General of India (DCGI) seeking approvals for its fast-acting insulin analog, Aspart injection. The company’s Aspart insulin injection ...

SIOUX FALLS, S.D. (KELO) — It’s an event that helps save lives one pint at a time, and on Tuesday it took place at KELOLAND TV. Community Blood Bank is a collaborative effort between Sanford ...

Shares of pharmaceutical and biotech company Wockhardt Ltd gained over 4% on Wednesday, October 16, to touch a 52-week high of ₹1087.95 apiece on the BSE. The sharp movement in the early deals was ...

Wockhardt Limited, the global pharmaceutical company, has submitted its indigenously developed fast-acting insulin analog, ASPARAPID, for regulatory approval with India’s Drugs Controller ...

Wockhardt Ltd., incorporated in the year 1999, is a Mid Cap company (having a market cap of Rs 16,414.05 Crore) operating in Pharmaceuticals sector. Wockhardt Ltd. key Products/Revenue Segments ...

Shares of Wockhardt Ltd jumped 4.32 per cent in Wednesday's trade to scale their one-year high value of Rs 1,127.25. The stock was last seen trading 1.71 per cent up at Rs 1,099. At this price ...